Item 7.01. Regulation FD Disclosure.

On January 13, 2020, Accuray Incorporated (the "Company") issued a press release regarding its intent to discuss business and revenue growth expectations for the next three fiscal years at the JP Morgan Healthcare Conference (the "Conference") on Wednesday, January 15, 2020. A copy of this press release is included as Exhibit 99.1 to this Current Report on Form 8-K.

Representatives of the Company intend to present the management presentation slides, attached hereto as Exhibit 99.2, during the Conference, which will be held on January 13-16, 2020. Such slides may be used in additional presentations to investors and analysts from time to time. The management presentation slides will also be posted on the investor relations portion of the Company's website.

The information contained in this Current Report on Form 8-K, including Exhibits 99.1 and 99.2, is furnished pursuant to Item 7.01 and shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be incorporated by reference into a filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.




Item 9.01.  Financial Statements and Exhibits.



(d)  Exhibits.



Exhibit No.                                 Description
99.1             Press Release dated January 13, 2020  .
99.2             Management Presenation Slides of Accuray Incorporated dated January
               15, 2020  .


                                       3

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses